Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
| Market Cap | 193.88M | P/E | 168.42 | EPS this Y | - | Ern Qtrly Grth | - |
| Income | 63.09k | Forward P/E | - | EPS next Y | - | 50D Avg Chg | 1.00% |
| Sales | - | PEG | - | EPS past 5Y | - | 200D Avg Chg | 3.00% |
| Dividend | N/A | Price/Book | N/A | EPS next 5Y | - | 52W High Chg | -3.00% |
| Recommedations | - | Quick Ratio | 5.94 | Shares Outstanding | 15.45M | 52W Low Chg | 5.00% |
| Insider Own | 3.23% | ROA | - | Shares Float | 13.47M | Beta | - |
| Inst Own | 85.32% | ROE | - | Shares Shorted/Prior | 24.82K/11.34K | Price | 10.11 |
| Gross Margin | - | Profit Margin | - | Avg. Volume | 206,578 | Target Price | - |
| Oper. Margin | - | Earnings Date | - | Volume | 5 | Change | 0.00% |
About Research Alliance Corp. II
Research Alliance Corp. II does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It identifies and acquires a business, focusing on the healthcare industry, such as in biotechnology sector. Research Alliance Corp. II was incorporated in 2020 and is based in Las Vegas, Nevada.